The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...
Cologuard Plus, a new version of the Cologuard colorectal screening test, became available in 2025. The manufacturer says the upgraded test may be 30% more accurate than the original Cologuard. If you ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MADISON (WKOW) — Exact Sciences has launched its new "Cologuard Plus" test. This test is gaining attention as the most accurate non-invasive colorectal screening test currently available. The ...
It's a rite of passage we don't look forward to: Once we turn 45, it's recommended that we get a colonoscopy to screen for polyps and colon cancer. This is especially important as rates of the disease ...
EXAS has a unique regulatory advantage as the FDA and Congress work on extending the regulatory arm over the gene diagnostics sector. Cologuard remains EXAS's growth engine going into 2024.
Exact Sciences Corp. demonstrated a significant increase in accuracy with the latest version of its Cologuard test for colorectal cancer in its pivotal BLUE-C study. Top-line results released this ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
(RTTNews) - Exact Sciences Corp. (EXAS) Monday has introduced Cologuard Plus, an FDA-approved noninvasive colorectal cancer - CRC screening test for average-risk adults aged 45 and older. It offers 95 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results